the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise Alone
Clinical trial NCT06650007 · COMPLETED
Trial details
- NCT number
- NCT06650007
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-08
- Primary completion
- 2026-01-21
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.